Collectively, our data highlight positive allosteric modulation of CD11b as a novel strategy for targeting TAM cell recruitment and polarization in TME to enhance both the innate and adaptive immune responses against lung cancer. This evidence concerns the gene ITGAM and lung carcinoma.